Acute myeloid leukemia, myelodysplastic syndromes
Conditions
Brief summary
The probability of progression-free survival in 24 month FU.
Detailed description
Frequency of adverse events in 24 month FU., 24-month overall survival probability., Disease recurrence probability., Mortality unrelated with disease recurrence., Likelihood of acute and chronic graft-versus-host disease., Time of neutrophil and platelet implantation.
Interventions
Sponsors
Narodowy Instytut Onkologii Im. Marii Sklodowskiej-Curie Panstwowy Instytut Badawczy
Eligibility
Sex/Gender
All
Age
18 Years to 64 Years
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The probability of progression-free survival in 24 month FU. | — |
Secondary
| Measure | Time frame |
|---|---|
| Frequency of adverse events in 24 month FU., 24-month overall survival probability., Disease recurrence probability., Mortality unrelated with disease recurrence., Likelihood of acute and chronic graft-versus-host disease., Time of neutrophil and platelet implantation. | — |
Countries
Poland
Outcome results
None listed